ATE135049T1 - Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode - Google Patents

Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Info

Publication number: ATE135049T1
Authority: AT; Austria
Prior art keywords: cystatin; producing; carrying; modifications; dna sequence
Prior art date: 1987-05-22

Application number

AT88904935T

Other languages

English (en)

Inventor

Anders Grubb

Ake Lundwall

Magnus Abrahamson

Henrik Dlaboge

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-22

Filing date

1988-05-20

Publication date

1996-03-15

1988-05-20 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1996-03-15 Application granted granted Critical

1996-03-15 Publication of ATE135049T1 publication Critical patent/ATE135049T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Dermatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Electronic Switches (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT88904935T 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode ATE135049T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK260987A DK260987D0 (da)	1987-05-22	1987-05-22	Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Publications (1)

Publication Number	Publication Date
ATE135049T1 true ATE135049T1 (de)	1996-03-15

Family

ID=8113675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88904935T ATE135049T1 (de)	1987-05-22	1988-05-20	Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Country Status (12)

Country	Link
EP (1)	EP0362259B1 (de)
JP (1)	JP3011274B2 (de)
AT (1)	ATE135049T1 (de)
AU (1)	AU619750B2 (de)
CA (1)	CA1340862C (de)
DE (1)	DE3855078T2 (de)
DK (1)	DK260987D0 (de)
ES (1)	ES2013337A6 (de)
FI (1)	FI102191B (de)
IL (1)	IL86476A (de)
NO (1)	NO301985B1 (de)
WO (1)	WO1988009384A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2002820A1 (en) *	1988-11-18	1990-05-18	Kazunori Hanada	Pharmaceutical use for cystatins
GB9122051D0 (en) *	1991-10-17	1991-11-27	Univ Nottingham	Medicines
GB9403819D0 (en) *	1994-02-28	1994-04-20	Univ Leeds	Control of parasites
AU738766B2 (en) *	1994-11-21	2001-09-27	University Of Leeds, The	Modified proteinase inhibitors
RU2182598C2 (ru) *	1994-11-21	2002-05-20	Новартис Аг	Модифицированные ингибиторы протеиназы
US6011012A (en)	1995-06-05	2000-01-04	Human Genome Sciences, Inc.	Human cystatin E
CA2223888A1 (en) *	1995-06-05	1996-12-12	Human Genome Sciences, Inc.	Human cystatin e
EP1123399A2 (de) *	1998-08-05	2001-08-16	The University Of British Columbia	Herstellung und verwendung von modifizierten cystatinen
AU2178000A (en) *	1998-12-11	2000-06-26	Salk Institute For Biological Studies, The	Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de)	2000-06-20	2005-01-12	Switch Biotech Aktiengesellschaft	Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
KR20180084159A (ko) *	2012-07-31	2018-07-24	유키지루시 메그밀크 가부시키가이샤	신규 단백질 소재
CN102895658A (zh) *	2012-08-23	2013-01-30	苏州大学附属第一医院	Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) *	2016-08-10	2016-11-16	吴江近岸蛋白质科技有限公司	表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4775624A (en) *	1985-02-08	1988-10-04	Eli Lilly And Company	Vectors and compounds for expression of human protein C

1987
- 1987-05-22 DK DK260987A patent/DK260987D0/da not_active Application Discontinuation
1988
- 1988-05-20 AU AU19399/88A patent/AU619750B2/en not_active Expired
- 1988-05-20 DE DE3855078T patent/DE3855078T2/de not_active Expired - Lifetime
- 1988-05-20 EP EP88904935A patent/EP0362259B1/de not_active Expired - Lifetime
- 1988-05-20 ES ES8801999A patent/ES2013337A6/es not_active Expired - Lifetime
- 1988-05-20 WO PCT/DK1988/000082 patent/WO1988009384A1/en not_active Ceased
- 1988-05-20 AT AT88904935T patent/ATE135049T1/de not_active IP Right Cessation
- 1988-05-20 JP JP63504682A patent/JP3011274B2/ja not_active Expired - Lifetime
- 1988-05-23 IL IL8647688A patent/IL86476A/en not_active IP Right Cessation
- 1988-05-24 CA CA000567916A patent/CA1340862C/en not_active Expired - Lifetime
1989
- 1989-01-20 NO NO890260A patent/NO301985B1/no not_active IP Right Cessation
- 1989-11-21 FI FI895553A patent/FI102191B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL86476A0 (en)	1988-11-15
EP0362259B1 (de)	1996-03-06
WO1988009384A1 (en)	1988-12-01
DE3855078D1 (de)	1996-04-11
JP3011274B2 (ja)	2000-02-21
CA1340862C (en)	1999-12-28
AU619750B2 (en)	1992-02-06
DK260987D0 (da)	1987-05-22
NO301985B1 (no)	1998-01-05
AU1939988A (en)	1988-12-21
IL86476A (en)	1994-01-25
FI102191B1 (fi)	1998-10-30
JPH03501201A (ja)	1991-03-22
FI895553A0 (fi)	1989-11-21
EP0362259A1 (de)	1990-04-11
DE3855078T2 (de)	1996-07-18
NO890260D0 (no)	1989-01-20
NO890260L (no)	1989-01-20
ES2013337A6 (es)	1990-05-01
FI102191B (fi)	1998-10-30

Similar Documents

Publication	Publication Date	Title
DE3855078D1 (de)	1996-04-11	Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE68928934D1 (de)	1999-04-01	Verfahren zur herstellung von menschlicher dnase
DE3888274D1 (de)	1994-04-14	Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE3177213D1 (de)	1990-10-18	Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
DE3583194D1 (de)	1991-07-18	Verfahren zur herstellung von einem polypeptid mittels eines transformierten mikroorganismus, ein dazu geeigneter transformierter mikroorganismus, und zur herstellung dieser mikroorganismen geeignete dns sequenzen.
PL272698A1 (en)	1989-03-06	Method for expressing human proapolyprotein a-j
DK0601360T3 (da)	1998-04-20	B-stamcellestimulerende faktor
DE3888048D1 (de)	1994-04-07	Verfahren zur Herstellung von durchsichtigen Polysiloxanelastomeren.
DE3660494D1 (en)	1988-09-15	Method for the manufacture of waterproof leather or fur
DE3885151D1 (de)	1993-12-02	Methode zur Herstellung von Methacrylatestern.
ATE81339T1 (de)	1992-10-15	Verfahren zur herstellung von zyklischen sulfaten.
DE68916086D1 (de)	1994-07-21	Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
PT83968A (de)	1987-01-01	Verfahren zur verbesserung des expression von eukaryontenprotein
DE3882453D1 (de)	1993-08-26	Verfahren zur herstellung von ibuprofen.
DE68908576D1 (de)	1993-09-30	Verfahren zur Herstellung von Aktivkohle.
DE3680445D1 (de)	1991-08-29	Verfahren zur herstellung von mesophilen mikroorganismen, die eine bei hoeherer temperatur aktive d-hydantoinase enthalten.
DE68914956D1 (de)	1994-06-01	Methode zur Herstellung von Dialkyl- und Diallyldicarbonaten.
ATE49185T1 (de)	1990-01-15	Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
DE3761088D1 (de)	1990-01-11	Verbessertes verfahren zur herstellung von p-cymol und homologen alkylbenzolen.
ATE45968T1 (de)	1989-09-15	Verfahrung zur herstellung von ungesaettigen polyestern.
ATE67986T1 (de)	1991-10-15	Verfahren zur herstellung von wasserstoffperoxid.
ES2125216T3 (es)	1999-03-01	Procedimiento para la produccion de polipeptidos recombinantes con actividad de hormona porcina del crecimiento.
DE3582368D1 (de)	1991-05-08	Verfahren zur herstellung von epoxyden mittels mikroorganismen.
DE69014042D1 (de)	1994-12-15	Verfahren zur Herstellung von menschlichem Osteocalcin.
DE3786870D1 (de)	1993-09-09	Methode zur herstellung von proteinen.

Legal Events

Date	Code	Title	Description
1996-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties